Home Biosimilar Antibodies Metabolism PCSK9 antibody Ongericimab (Anti-PCSK9) For research use only.
Not for use in humans.

Ongericimab (Anti-PCSK9)

Synonyms: JS002

Ongericimab (Anti-PCSK9) is a humanized monoclonal antibody targeting PCSK9. It has lipid-lowering efficacy and can be used in research of hypercholesteremia and hyperlipidemia. MW :143.04 KD.

Ongericimab (Anti-PCSK9)

Purity & Quality Control

≥99

Choose Selective PCSK9 Inhibitors

Biological Activity

Description Ongericimab (Anti-PCSK9) is a humanized monoclonal antibody targeting PCSK9. It has lipid-lowering efficacy and can be used in research of hypercholesteremia and hyperlipidemia. MW :143.04 KD.

Product Details

CAS No. 2145096-91-7
Molecular Weight 143.04
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ongericimab (Anti-PCSK9) | Ongericimab (Anti-PCSK9) supplier | purchase Ongericimab (Anti-PCSK9) | Ongericimab (Anti-PCSK9) cost | Ongericimab (Anti-PCSK9) manufacturer | order Ongericimab (Anti-PCSK9) | Ongericimab (Anti-PCSK9) distributor